Endocrinology, Vol 110, 506-512, Copyright © 1982 by Endocrine Society

ARTICLES

Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration

CS Tam, JN Heersche, TM Murray and JA Parsons

The deposition of mineralized bone matrix by differentiated osteoblasts was studied in rats in vivo by labeling the bone with three doses of tetracycline given at 48-h intervals. Only bone formation loci bearing all three tetracycline doses were measured, thus eliminating sites where bone formation was not continuous during the labeling period. Using this technique, the effects of intact bovine parathyroid hormone [bPTH-(1-84)] and of a synthetic amino-terminal fragment of human PTH [hPTH-(1-34)] were measured in thyroparathyroidectomized animals. bPTH- (1-84), administered sc, and hPTH-(1-34), administered iv, caused a dose-dependent increase in the bone apposition. Subcutaneous administration of hPTH-(1-34) in doses varying from 2.7-173.0 pmol/rat.day had no effect, probably due to the degradation of the hormone when administered this way. We also compared the effects of bPTH-(1-84) when administered by either daily sc injections or continuous infusion. Continuous infusion of bPTH-(1-84) resulted in an increased apposition rate. Using a morphometric technique, we also found an increase in both formation and resorption surfaces and a net decrease in the trabecular bone volume in this group. Daily injection of the hormone caused an increase in the bone apposition rate, accompanied by an increase in the formation surface without an increase in the resorption surface. This resulted in a net increase in trabecular bone volume. The results thus suggest that the resorptive effects of bPTH-(1-84) can be separated from the effects of the hormone on the apposition rate.

This article has been cited by other articles:

				Y.-W. Qiang, J. D. Shaughnessy Jr, and S. Yaccoby Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth Blood, July 15, 2008; 112(2): 374 - 382. [Abstract] [Full Text] [PDF]

				M. Ferron, E. Hinoi, G. Karsenty, and P. Ducy Osteocalcin differentially regulates {beta} cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice PNAS, April 1, 2008; 105(13): 5266 - 5270. [Abstract] [Full Text] [PDF]

				L. J. Raggatt, L. Qin, J. Tamasi, S. C. Jefcoat Jr., E. Shimizu, N. Selvamurugan, F. Y. Liew, L. Bevelock, J. H. M. Feyen, and N. C. Partridge Interleukin-18 Is Regulated by Parathyroid Hormone and Is Required for Its Bone Anabolic Actions J. Biol. Chem., March 14, 2008; 283(11): 6790 - 6798. [Abstract] [Full Text] [PDF]

				D. G. Little, M. Ramachandran, and A. Schindeler The anabolic and catabolic responses in bone repair J Bone Joint Surg Br, April 1, 2007; 89-B(4): 425 - 433. [Abstract] [Full Text] [PDF]

				D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF]

				Y.-H. Wang, Y. Liu, and D. W. Rowe Effects of transient PTH on early proliferation, apoptosis, and subsequent differentiation of osteoblast in primary osteoblast cultures Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E594 - E603. [Abstract] [Full Text] [PDF]

				Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Exogenous 1,25-Dihydroxyvitamin D3 Exerts a Skeletal Anabolic Effect and Improves Mineral Ion Homeostasis in Mice that Are Homozygous for Both the 1{alpha}-Hydroxylase and Parathyroid Hormone Null Alleles Endocrinology, October 1, 2006; 147(10): 4801 - 4810. [Abstract] [Full Text] [PDF]

				D. Gesty-Palmer, M. Chen, E. Reiter, S. Ahn, C. D. Nelson, S. Wang, A. E. Eckhardt, C. L. Cowan, R. F. Spurney, L. M. Luttrell, et al. Distinct beta-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation J. Biol. Chem., April 21, 2006; 281(16): 10856 - 10864. [Abstract] [Full Text] [PDF]

				N. Young, N. Mikhalkevich, Y. Yan, D. Chen, and W.-p. Zheng Differential Regulation of Osteoblast Activity by Th Cell Subsets Mediated by Parathyroid Hormone and IFN-{gamma} J. Immunol., December 15, 2005; 175(12): 8287 - 8295. [Abstract] [Full Text] [PDF]

				J. T Potts Parathyroid hormone: past and present J. Endocrinol., December 1, 2005; 187(3): 311 - 325. [Abstract] [Full Text] [PDF]

				A. Fleming, M. Sato, and P. Goldsmith High-Throughput In Vivo Screening for Bone Anabolic Compounds with Zebrafish J Biomol Screen, December 1, 2005; 10(8): 823 - 831. [Abstract] [PDF]

				C. A. O'Brien, R. L. Jilka, Q. Fu, S. Stewart, R. S. Weinstein, and S. C. Manolagas IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E784 - E793. [Abstract] [Full Text] [PDF]

				L Maimoun, D Simar, D Malatesta, C Caillaud, E Peruchon, I Couret, M Rossi, and D Mariano-Goulart Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects Br. J. Sports Med., August 1, 2005; 39(8): 497 - 502. [Abstract] [Full Text] [PDF]

				Y. M. Alkhiary, L. C. Gerstenfeld, E. Krall, M. Westmore, M. Sato, B. H. Mitlak, and T. A. Einhorn Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34) J. Bone Joint Surg. Am., April 1, 2005; 87(4): 731 - 741. [Abstract] [Full Text] [PDF]

				L. Qin, J. Tamasi, L. Raggatt, X. Li, J. H. M. Feyen, D. C. Lee, E. DiCicco-Bloom, and N. C. Partridge Amphiregulin Is a Novel Growth Factor Involved in Normal Bone Development and in the Cellular Response to Parathyroid Hormone Stimulation J. Biol. Chem., February 4, 2005; 280(5): 3974 - 3981. [Abstract] [Full Text] [PDF]

				S. Bonadonna, A. Burattin, M. Nuzzo, G. Bugari, E. A. Rosei, D. Valle, N. Iori, J. P Bilezikian, J. D Veldhuis, and A. Giustina Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects Eur. J. Endocrinol., February 1, 2005; 152(2): 199 - 205. [Abstract] [Full Text] [PDF]

				M. Homme, C. P. Schmitt, O. Mehls, and F. Schaefer Mechanisms of Mitogen-Activated Protein Kinase Inhibition by Parathyroid Hormone in Osteoblast-Like Cells J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2844 - 2850. [Abstract] [Full Text] [PDF]

				D. K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G. N. Hendy, and D. Goltzman Inactivation of the 25-Hydroxyvitamin D 1{alpha}-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis J. Biol. Chem., April 16, 2004; 279(16): 16754 - 16766. [Abstract] [Full Text] [PDF]

				G. R. Madore, P. J. Sherman, and J. M. Lane Parathyroid Hormone J. Am. Acad. Ortho. Surg., March 1, 2004; 12(2): 67 - 71. [Full Text] [PDF]

				K. H. Mikulec, L. Holloway, R. E. Krasnow, H. Javitz, G. E. Swan, T. Reed, R. Marcus, and D. Carmelli Relationship of Endogenous Sex Hormones to Coronary Heart Disease: A Twin Study J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1240 - 1245. [Abstract] [Full Text] [PDF]

				K. A Cappuzzo and J. C Delafuente Teriparatide for Severe Osteoporosis Ann. Pharmacother., February 1, 2004; 38(2): 294 - 302. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF]

				M. Homme, C. P. Schmitt, R. Himmele, G. F. Hoffmann, O. Mehls, and F. Schaefer Vitamin D and Dexamethasone Inversely Regulate Parathyroid Hormone-Induced Regulator of G Protein Signaling-2 Expression in Osteoblast-Like Cells Endocrinology, June 1, 2003; 144(6): 2496 - 2504. [Abstract] [Full Text] [PDF]

				C. Crandall Parathyroid Hormone for Treatment of Osteoporosis Arch Intern Med, November 11, 2002; 162(20): 2297 - 2309. [Abstract] [Full Text] [PDF]

				B. Demiralp, H.-L. Chen, A. J. Koh, E. T. Keller, and L. K. McCauley Anabolic Actions of Parathyroid Hormone during Bone Growth Are Dependent on c-fos Endocrinology, October 1, 2002; 143(10): 4038 - 4047. [Abstract] [Full Text] [PDF]

				M. Shimada, X. Chen, T. Cvrk, H. Hilfiker, M. Parfenova, and G. V. Segre Purification and Characterization of a Receptor for Human Parathyroid Hormone and Parathyroid Hormone-related Peptide J. Biol. Chem., August 23, 2002; 277(35): 31774 - 31780. [Abstract] [Full Text] [PDF]

				R. Gopalakrishnan, H. Ouyang, M. J. Somerman, L. K. McCauley, and R. T. Franceschi Matrix {gamma}-Carboxyglutamic Acid Protein Is a Key Regulator of PTH-Mediated Inhibition of Mineralization in MC3T3-E1 Osteoblast-Like Cells Endocrinology, October 1, 2001; 142(10): 4379 - 4388. [Abstract] [Full Text] [PDF]

				R. M. Neer, C. D. Arnaud, J. R. Zanchetta, R. Prince, G. A. Gaich, J.-Y. Reginster, A. B. Hodsman, E. F. Eriksen, S. Ish-Shalom, H. K. Genant, et al. Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis N. Engl. J. Med., May 10, 2001; 344(19): 1434 - 1441. [Abstract] [Full Text] [PDF]

				M. Horwitz, A. Stewart, and S. L. Greenspan Editorial: Sequential Parathyroid Hormone/Alendronate Therapy for Osteoporosis--Robbing Peter to Pay Paul? J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2127 - 2128. [Full Text]

				S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text]

				C. P. Schmitt and F. Schaefer Calcium sensitivity of the parathyroid in renal failure: another look with new methodology Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2815 - 2818. [Full Text] [PDF]

				E. Eklou-Kalonji, E. Zerath, C. Colin, C. Lacroix, X. Holy, I. Denis, and A. Pointillart Calcium-Regulating Hormones, Bone Mineral Content, Breaking Load and Trabecular Remodeling Are Altered in Growing Pigs Fed Calcium-Deficient Diets J. Nutr., January 1, 1999; 129(1): 188 - 193. [Abstract] [Full Text] [PDF]

				K. K. Winer, J. A. Yanovski, B. Sarani, and G. B. Cutler Jr. A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1-34 in Treatment of Hypoparathyroidism J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3480 - 3486. [Abstract] [Full Text]

				J. S. Finkelstein, A. Klibanski, A. L. Arnold, T. L. Toth, M. D. Hornstein, and R. M. Neer Prevention of Estrogen Deficiency-Related Bone Loss With Human Parathyroid Hormone-(1-34): A Randomized Controlled Trial JAMA, September 23, 1998; 280(12): 1067 - 1073. [Abstract] [Full Text] [PDF]

				H. Dobnig and R. T. Turner The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1-34) on Bone Histomorphometry and Serum Chemistry in Rats Endocrinology, November 1, 1997; 138(11): 4607 - 4612. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF]

				A. Toromanoff, P. Ammann, L. Mosekilde, J. S. Thomsen, and J.-L. Riond Parathyroid Hormone Increases Bone Formation and Improves Mineral Balance in Vitamin D-Deficient Female Rats Endocrinology, June 1, 1997; 138(6): 2449 - 2457. [Abstract] [Full Text] [PDF]

				R. Yang and L. C. Gerstenfeld Signal Transduction Pathways Mediating Parathyroid Hormone Stimulation of Bone Sialoprotein Gene Expression in Osteoblasts J. Biol. Chem., November 22, 1996; 271(47): 29839 - 29846. [Abstract] [Full Text] [PDF]

				A. Hollnagel, D. Schroder, and G. Gross Domain-specific Gene Activation by Parathyroid Hormone in Osteoblastic ROS17/2.8 Cells J. Biol. Chem., September 6, 1996; 271(36): 21870 - 21877. [Abstract] [Full Text] [PDF]

				J. S. Finkelstein, A. Klibanski, E. H. Schaefer, M. D. Hornstein, I. Schiff, and R. M. Neer Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency N. Engl. J. Med., December 15, 1994; 331(24): 1618 - 1623. [Abstract] [Full Text]